Answering Your Questions on Developing a Relative Potency Assay for an Anti-Influenza mAb

Posted by Dr. Jeff Patrick / May 22, 2020 / BioAgilytix Insight, Vaccines, Viruses

Dr. Jeff Patrick answers questions on how BioAgilytix translated a diagnostic virus neutralization method to a quantitative relative potency assay for an anti-viral antibody.